Building a comprehensive aortic aneurysm and dissection prediction model incorporating genetic and non-genetic factors
Building a comprehensive aortic aneurysm and dissection prediction model incorporating genetic and non-genetic factors
批准号:
MR/T023783/1
负责人:
John Danesh
金额:
$34.79万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
迫切需要确定有主动脉瘤和夹层风险的个体,因为这种情况通常是沉默的,直到发生灾难性的并发症,如破裂或夹层。及早识别高危人群可以采取预防措施,如血压控制和预防性手术。用横断面成像对整个人群进行胸主动脉疾病筛查既不实用,也不安全,在经济上也不可行。然而,对高危个体(例如患者的一级亲属)进行筛查可能是合理的。目前腹主动脉瘤的筛查方案收效率较低(约1%的受检者有AAA),约10%的主动脉破裂发生在英国目前倡导的筛查年龄以下。AAA筛查也受到以下事实的限制:女性没有得到筛查(尽管占AAA相关死亡的42%)。在乳腺癌方面,已经表明,在国家筛查计划中增加遗传和或临床信息,有可能减少符合正式筛查测试的人口比例,识别出风险最高的年轻个体(目前没有资格进行筛查),并减少筛查的危害(如过度诊断/治疗)。这些因素在AAD中是相关的,但尚未得到评估。对AAD的易感性具有很强的遗传成分,低风险的常见遗传变异、中等风险的罕见变异和高度渗透的非常罕见的遗传变异都起到了作用。在精确医学模式下,使用遗传和/或其他临床数据可以识别出主动脉疾病的高危个体,从而可以制定个性化的筛查和预防措施。在这项研究计划中,我们的目标是量化AAD的绝对风险,按年龄、性别、临床和遗传风险因素分层,使用来自OxVasc研究的UKBiobank和主要发病数据。当这项工作完成后,我们将能够模拟分层筛查算法的潜在可行性。作为扩展,我们的目标是表征人群中无症状个体携带的罕见、中等风险变异的表型后果。为了做到这一点,我们将在英国生物库中评估这些携带者的影像表现,并对招募到UKInterval研究中的个体进行按基因召回的研究。罕见、中等风险变异的携带者将被召回进行详细的表型评估,包括高级主动脉成像研究。
英文摘要
There is an urgent need to identify individuals at risk of aortic aneurysms and dissections as the condition is usually silent until a catastrophic complication such as rupture or dissection occurs. Early identification of those at elevated risk may allow preventative measures, such as blood pressure control and prophylactic surgery, to be instituted. Screening the entire population for thoracic aortic disease with cross-sectional imaging is not practical, safe or financially feasible. Screening may be justified, however, in high risk individuals (for example first degree relatives of patients). The current screening program for abdominal aortic aneurysm has a low-yield (~1% of all those scanned have a AAA) and approximately 10% of aortic ruptures occur below the age of screening currently advocated in the UK. AAA screening is also limited by the fact that females are not offered screening (despite representing 42% of AAA related deaths). In breast cancer it has been shown that addition of genetic and or clinical information to national screening programs has the potential to reduce the proportion of the population eligible for formal screening tests, identify younger individuals at highest risk (currently ineligible for screening) and reduce the harms of screening (such as overdiagnosis/treatment). These factors are relevant in AAD but as yet have not been evaluated.Susceptibility to AAD has a strong genetic component and low-risk common genetic variants, intermediate risk rare variants and highly penetrant very rare genetic variants all play a role. Under a precision medicine model, the use of genetic and/or other clinical data may identify individuals at high risk of aortic diseases may allow development of personalised screening and prevention measures. In this program of research we aim to quantify the absolute risk of AAD, stratified by age, gender, clinical and genetic risk factors using both the UKBiobank and primary incidence data derived from the OxVasc study. When this has been performed we will be able to model the potential feasibility of stratified screening algorithm.As an extension to this, we aim to characterise the phenotypic consequence of rare, intermediate risk variants that are carried by asymptomatic individuals in the population. In order to do this we will evaluate imaging findings of such carriers in the UKBiobank and also perform a recall by genotype study for individuals recruited to the UKInterval study. Carriers of rare, intermediate risk variants will be recalled for detailed phenotypic evaluation including advanced aortic imaging studies.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0253327
发表时间:
2021
期刊:
PloS one
影响因子:
3.7
作者:
[Kim LG, Sweeting MJ, Armer M, Jacomelli J, Nasim A, Harrison SC]
通讯作者:
Harrison SC
Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemic
模拟 COVID-19 大流行期间英格兰腹主动脉瘤筛查和治疗服务变化的影响
DOI:
10.17863/cam.71408
发表时间:
2021
期刊:
影响因子:
--
作者:
[Kim L]
通讯作者:
Kim L
Molecules to Health Records
-
批准号:HDR-23007
-
项目类别:Intramural
-
资助金额:$762.35万
-
财政年份:2023
-
负责人:John Danesh
-
依托单位:
Cambridge Alliance to Protect Bangladesh from Long-term Environmental Hazards (CAPABLE)
-
批准号:MR/P02811X/1
-
项目类别:Research Grant
-
资助金额:$1036.46万
-
财政年份:2017
-
负责人:John Danesh
-
依托单位:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
-
批准号:MR/L003120/1
-
项目类别:Research Grant
-
资助金额:$257.11万
-
财政年份:2013
-
负责人:John Danesh
-
依托单位:
Study of the interplay of genetic, biochemical, and lifestyle factors on coronary heart disease incidence
-
批准号:G0800270/1
-
项目类别:Research Grant
-
资助金额:$379.35万
-
财政年份:2010
-
负责人:John Danesh
-
依托单位:
Statistical methodology for meta-analysis of epidemiological studies using individual participant data.
-
批准号:G0700463/1
-
项目类别:Research Grant
-
资助金额:$31.93万
-
财政年份:2009
-
负责人:John Danesh
-
依托单位:
A pilot study for the establishment of large-scale bioresources by linking blood donor samples with electronic heal
-
批准号:MC_qA137933
-
项目类别:Intramural
-
资助金额:$44.64万
-
财政年份:2009
-
负责人:John Danesh
-
依托单位:
Reliable evaluation of associations between Lp-PLA2 markers and the risk of cardiovascular outcomes
-
批准号:G0601284/1
-
项目类别:Research Grant
-
资助金额:$39.65万
-
财政年份:2007
-
负责人:John Danesh
-
依托单位:
Triglycerides and cardiovascular disease: meta-analysis of individual data on 600 000 participants in 60 studies
-
批准号:G0501792/1
-
项目类别:Research Grant
-
资助金额:$47.27万
-
财政年份:2006
-
负责人:John Danesh
-
依托单位:
海外基金